DreamCIS, Inc. (223250.KQ)
KOSDAQ · KRW · Healthcare · Medical Care Facilities
₩3,955 (+5.33%) as of
Key statistics
- Market cap
- 97.29B
- Forward P/E
- 7.58
- Dividend yield
- 0.00%
- 52-week range
- 2,360.00 – 8,640.00
- Beta
- 0.56
- Revenue (TTM)
- 73.28B
- Profit margin
- 0.45%
- Volume
- 449.80k
About DreamCIS, Inc.
DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada. It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Seoul, South Korea
- Employees
- 390
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.